CS logo
small CS logo
CCRN

Brampton, Ontario, Canada
Laboratory in Brampton, Ontario
3 Conestoga Dr, Brampton, ON L6Z 4N5

About CCRN


"Physician Organization"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at CCRN


During the past decade, CCRN conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
1995-02-01
Completed
3,300
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
2001-06-01
2009-12-01
Completed
3,010
Combination Chemotherapy in Treating Women With Stage I Breast Cancer
2002-08-01
2013-06-01
Completed
1,512
Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ
2003-09-01
2021-05-31
Completed
2,980
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
2003-11-01
Unknown status
Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)
2005-05-01
Completed
700
Trastuzumab for 6 Months or 1 Year in Treating Women With Nonmetastatic Breast Cancer That Can Be Removed By Surgery
2006-05-01
Completed
3,400
Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery
2008-02-01
2014-09-01
Completed
820

Rows per page:

1–30 of 30

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "CCRN" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at CCRN


According to Clinical.Site data, the most researched conditions in "CCRN" are "Cardiovascular Diseases" (2 trials). Many other conditions were trialed in "CCRN" in a lesser frequency.

Clinical Trials Intervention Types at CCRN


Clinical Trials Genders at CCRN


The vast majority of trials in "CCRN" are 2 trials for "All" genders.

Clinical Trials Status at CCRN


Currently, there are NaN active trials in "CCRN". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CCRN, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CCRN, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status